Search

everythinglearnresearchcommunity

for

Search:↓

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Platelet-Rich Plasma (PRP) helps reduce jaw pain and improve function in young adults with mild TMJ disorder.

Serotonin helps wounds heal faster.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

ATP helps prevent skin damage from vandetanib by reducing stress.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The enzyme Rand protease works well for leather dehairing and its stability is important, with Leu75 playing a key role.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Finasteride may affect PNMT, causing side effects.

A new gene mutation caused a man's rare skin condition, Schöpf-Schulz-Passarge syndrome.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.